External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer

NCT01603420 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

2

Enrollment

NETWORK

Sponsor class

Stopped enrollment goals not met

Conditions

Prostate Cancer

Interventions

DRUG: Luteinizing hormone-releasing hormone (LHRH)
DRUG: Docetaxel
OTHER: Conformal Radiation Therapy (RT)

Sponsor

Proton Collaborative Group